PEDIATRICS Vol. 56 No. 1 July 1975, pp. 91-99
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Talamo, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Talamo, R. C.

Basic and Clinical Aspects of the Alpha1-Antitrypsin

Richard C. Talamo M.D.1

1 Division of Immunology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland

A deficiency of the major serum agr1-globulin, the agr1-antitrypsin, was first described in five patients by Laurell and Eriksson in Sweden in 1963. It soon became obvious that severe agr1-antitrypsin deficiency was familial, and highly associated with chronic lung disease, having its onset in the third or fourth decade of life. Since the early descriptions of this common deficiency state, it has become clearly associated with familial emphysema in some families, familial infantile cirrhosis in others, and occasionally with a combination of childhood lung and liver disease in siblings. For the pediatrician, severe agr1-antitrypsin deficiency now enters into the differential diagnosis of both chronic pulmonary disease in childhood and obstructive jaundice in the newborn period. In addition, low levels of agr1-anrirtysin in serum are characteristic of respiratory distress syndrome, and elevations of this protein may be found in a variety of clinical situations.

The agr1-antitrypsin probably functions as a major control protein against the tissue-damaging effects of both endogenous and exogenous enzymes. This review will cover several basic and clinical features of this protein with respect to its importance in pediatrics.

CHEMISTRY AND METABOLISM

A 50,000 molecular weight glycoprotein, the agr1-antitrypsin is synthesized in the parenchymal cells of the liver and is secreted into serum as the major agr1-globulin, comprising approximately 4% of the total serum protein level (normal concentrations are approximately 2.2 mg/ml). Alpha1-antitrypsin is present in many body fluids, having been found in microgram per milliliter quantities in nasal secretions, tears, saliva, pulmonary secrelions, duodenal fluid, cerebrospinal fluid, cobstrum, and mother's milk.

Submitted on November 18, 1974
Accepted on December 9, 1974




This article has been cited by other articles:


Home page
 CLIN PEDIATRHome page
Th. Karpathios, A. Fretzayas, P. Nicolaidou, and S. Haidas
"Classic" Galactosemia Associated with Alpha1-antitrypsin Deficiency
Clinical Pediatrics, December 1, 1983; 22(12): 828 - 830.
[PDF]